Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
This research-grade blend combines CJC-1295 (without DAC) and Ipamorelin, two synthetic peptides studied for their synergistic effects on growth hormone release. CJC-no DAC is a modified GHRH analog designed to promote pulsatile GH secretion, while Ipamorelin is a selective ghrelin receptor agonist known for its targeted stimulation of GH without affecting cortisol or prolactin levels. Together, they are investigated for potential roles in tissue repair, lean mass support, and recovery enhancement.
This research-grade blend combines CJC-1295 (without DAC) and Ipamorelin, two synthetic peptides studied for their synergistic effects on growth hormone release. CJC-no DAC is a modified GHRH analog designed to promote pulsatile GH secretion, while Ipamorelin is a selective ghrelin receptor agonist known for its targeted stimulation of GH without affecting cortisol or prolactin levels. Together, they are investigated for potential roles in tissue repair, lean mass support, and recovery enhancement.